Market Closed -
Other stock markets
|
After market 04:59:58 pm | |||
5.7 EUR | -1.21% | 5.705 | +0.09% |
Jan. 30 | Nanobiotix Gets $20 Million Milestone Payment in Phase 3 Trial for Potential Head, Neck Cancer Drug | MT |
Jan. 30 | Nanobiotix: targets achieved for NANORAY-312 | CF |
- Stock
- Equities
- Stock Nanobiotix - Euronext Paris
- News Nanobiotix